Immunogenicity of ORFV-based vectors expressing the rabies virus glycoprotein in livestock species

6Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

The parapoxvirus Orf virus (ORFV) encodes several immunomodulatory proteins (IMPs) that modulate host-innate and pro-inflammatory responses and has been proposed as a vaccine delivery vector for use in animal species. Here we describe the construction and characterization of two recombinant ORFV vectors expressing the rabies virus (RABV) glycoprotein (G). The RABV-G gene was inserted in the ORFV024 or ORFV121 gene loci, which encode for IMPs that are unique to parapoxviruses and inhibit activation of the NF-κB signaling pathway. The immunogenicity of the resultant recombinant viruses (ORFV ∆024 RABV-G or ORFV ∆121 RABV-G, respectively) was evaluated in pigs and cattle. Immunization of the target species with ORFV ∆024 RABV-G and ORFV ∆121 RABV-G elicited robust neutralizing antibody responses against RABV. Notably, neutralizing antibody titers induced in ORFV ∆121 RABV-G-immunized pigs and cattle were significantly higher than those detected in ORFV ∆024 RABV-G-immunized animals, indicating a higher immunogenicity of ORFV Δ121 -based vectors in these animal species.

Cite

CITATION STYLE

APA

Martins, M., Joshi, L. R., Rodrigues, F. S., Anziliero, D., Frandoloso, R., Kutish, G. F., … Diel, D. G. (2017). Immunogenicity of ORFV-based vectors expressing the rabies virus glycoprotein in livestock species. Virology, 511, 229–239. https://doi.org/10.1016/j.virol.2017.08.027

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free